Capecitabine plus Oxaliplatin as a Second-Line Therapy for Advanced Biliary Tract Cancers: A multicenter, open-label, phase II trial
- Seung Tae Kim
- , Sung Yong Oh
- , Jeeyun Lee
- , Jung Hun Kang
- , Hyun Woo Lee
- , Myung Ah Lee
- , Byeong Seok Sohn
- , Ji Hyong Hong
- , Young Suk Park
- , Joon Oh Park
- , Ho Yeong Lim
- Sungkyunkwan University
- Dong-A University
- Gyeongsang National University
- Ajou University
- The Catholic University of Korea
- Inje University
Research output: Contribution to journal › Article › peer-review
8
Link opens in a new tab
Scopus
citations